Head and neck mucosal malignant melanoma: Clinicopathologic correlation with contemporary review of prognostic indicators

International Journal of Surgical Pathology

Volumn 20, Issue 1, 2012, Pages 37-46

  Kerr, Elizabeth H ^a   Hameed, Omar ^a   Lewis, James S ^b   Bartolucci, Alfred A ^a   Wang, Dezhi ^a   Said Al Naief, Nasser ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

head and neck; melanoma; mucosal; oral cavity; sinonasal

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATIONAL STUDY; EPITHELIOID CELL; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HISTOLOGY; HUMAN; LIVER METASTASIS; LUNG METASTASIS; MALE; METASTASIS; MITOSIS; MOUTH CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SKIN PIGMENTATION; ULCER;

EID: 84859383563     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896911417970     Document Type: Article

References (38)

1. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and non-cutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer. 1998;83:1664-1678. (Pubitemid 28465486)
2. Bachar G, Loh KS, O'Sullivan B, et al. Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital. Head Neck. 2008;30:1325-1331.
3. Moreno MA, Roberts DB, Kupferman ME, et al. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center. Cancer. 2010;116:2215-2223.
4. Patel SG, Prasad ML, Escrig M, et al. Primary malignant mucosal melanoma of the head and neck. Head Neck. 2002;24:247-257. (Pubitemid 34193249)
5. Prasad ML, Patel SG, Huvos AG, Shah JP, Busam KJ. Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, stage 1 (lymph node-negative) tumors. Cancer. 2004;100:1657-1664. (Pubitemid 38456343)
6. Mckee PH, Calonje E, Granter SR, eds. Pathology of the Skin: With Clinical Correlation. Philadelphia, PA: Mosby; 2005.
7. McHenry PM, Hole DJ, MacKie RM. Melanoma in people aged 65 and over in Scotland, 1979-89. BMJ. 1992;304: 746-749.
8. Garbe C, Orfanos CE. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society. Pigment Cell Res. 1992;2:285-294.
9. Homsi J, Kashani-Sabet M, Messina JL, Daud A. Cutaneous melanoma: prognostic factors. Cancer Control. 2005;12:223-229. (Pubitemid 41552313)
10. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19: 3635-3648. (Pubitemid 32786276)
11. Zettersten E, Sagebiel RW, Miller JR, Tallapureddy S, Leong SP, Kashani-Sabet M. Prognostic factors in patients with thick cutaneous melanoma (>4 mm). Cancer. 2002;94: 1049-1056. (Pubitemid 34150860)
12. Owen SA, Sanders LL, Edwards LJ, Seigler HF, Tyler DS, Grichnik JM. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV. Cancer. 2001;91:983-991.
13. Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006;24:4340-4346. (Pubitemid 46630793)
14. Mendenhall WM, Amdur RJ, Hinerman RW, Werning JW, Villaret DB, Mendenhall NP. Head and neck mucosal melanoma. Am J Clin Oncol. 2005;28:626-630. (Pubitemid 41790018)
15. Wagner M, Morris CG, Werning JW, Mendenhall WM. Mucosal melanoma of the head and neck. Am J Clin Oncol. 2008;31:43-48.
16. McLean N, Tighiouart M, Muller S. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma. Oral Oncol. 2008;44:1039-1046.
17. Yanagi T, Mizoe JE, Hasegawa A, et al. Mucosal malignant melanoma of the head and neck treated by carbon ion radiotherapy. Int J Radiat Oncol Biol Phys. 2009;74:15-20.
18. Hoyt DJ, Jordan T, Fisher SR. Mucosal melanoma of the head and neck. Arch Otolyaryngol Head Neck Surg. 1989;115:1096-1099. (Pubitemid 19226281)
19. Meleti M, Leemans CR, de Bree R, Vescovi P, Sesenna E, van der Waal I. Head and neck mucosal melanoma: experience with 42 patients, with emphasis on the role of postoperative radiotherapy. Head Neck. 2008;30:1543-1551.
20. Panje WR, Moran WJ. Melanoma of the upper aerodigestive tract: a review of 21 cases. Head Neck Surg. 1986;8:309-312.
21. Krengli M, Masini L, Kaanders JH, et al. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A Rare Cancer Network study. Int J Radiat Oncol Biol Phys. 2006;65:751-759. (Pubitemid 43795842)
22. Stern SJ, Guillamondegui OM. Mucosal melanoma of the head and neck. Head Neck. 1991;13:22-27.
23. Manolidis S, Donald PJ. Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer. 1997;80:1373-1386. (Pubitemid 27441010)
24. Tomicic J, Wanebo HJ. Mucosal melanomas. Surg Clin North Am. 2003;83:237-252. (Pubitemid 36514808)
25. Prasad ML, Patel S, Hoshaw-Woodard S, et al. Prognostic factors for malignant melanoma of the squamous mucosa of the head and neck. Am J Surg Pathol. 2002;26: 883-892. (Pubitemid 34747640)
26. Shah JP, Huvos AG, Strong EW. Mucosal melanomas of the head and neck. Am J Surg. 1977;134:531-535. (Pubitemid 8201801)
27. Thompson LD, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol. 2003;27:594-611. (Pubitemid 36514471)
28. Satzger I, Schaefer T, Kuettler U, et al. Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas. Br J Cancer. 2008;99:2065-2069.
29. Flaherty KT. Chemotherapy and targeted therapy combinations in advanced melanoma. Clin Cancer Res. 2006;12: 2366s-2370s.
30. McCubrey JA, Milella M, Tafuri A, et al. Targeting the Raf/ MEK/ERK pathway with small-molecule inhibitors. Curr Opin Investig Drugs. 2008;9:614-630. (Pubitemid 351777165)
31. Russo AE, Torrisi E, Bevelacqua Y, et al. Melanoma: molecular pathogenesis and emerging target therapies. Int J Oncol. 2009;34:1481-1489.
32. McCubrey JA, Steelman LS, Chappell WH, et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta. 2007;1773:1263-1284.
33. McCubrey JA, Milella M, Tafuri A, et al. Targeting the Raf/ MEK/ERK pathway with small-molecule inhibitors. Curr Opin Investig Drugs. 2008;9:614-630. (Pubitemid 351777165)
34. Cohen C, Zavala-Pompa A, Sequeira JH, et al. Mitogen-actived protein kinase activation is an early event in melanoma progression. Clin Cancer Res. 2002;8:3728-3733. (Pubitemid 35424762)
35. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949-954. (Pubitemid 34716871)
36. Libra M, Malaponte G, Navolanic PM, et al. Analysis of BRAF mutation in primary and metastatic melanoma. Cell Cycle. 2005;4:1382-1384. (Pubitemid 41437127)
37. Curtin JA, Fridlyand J, Kageshita T, et al. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353: 2135-2147. (Pubitemid 41653105)
38. Mauerer A, Roesch A, Hafner C, et al. Identification of new genes associated with melanoma. Exp Dermatol. 2011;6: 502-507.